CytoVale is a Biotech company based in San Francisco, CA. It has raised $180M in total funding. Latest round: Series D.
CytoVale is a Biotech company based in San Francisco, CA. CytoVale has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in October 2024. The round record for CytoVale runs through 2024; nothing later has been disclosed. Investors on record include Sands Capital, Norwest Venture Partners, Global Health Investment Corporation (GHIC), Entree Capital, Samsung Next, Blackhorn Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
CytoVale totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Francisco below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026